Summary
This comprehensive narrative review synthesises the existing literature on the chemo-preventive and therapeutic potential of dietary phytochemicals in relation to bladder cancer. It likely covers a range of bioactive plant compounds, discussing their molecular targets, signalling pathways affected, and the strength of preclinical and clinical evidence supporting their role in reducing bladder cancer risk or improving treatment outcomes. The review contributes to a growing body of evidence linking dietary phytochemical intake to cancer risk modulation, with implications for nutritional oncology and public health recommendations.
UK applicability
Although not UK-specific, the findings are broadly applicable to UK public health and oncology contexts, particularly given the relevance of dietary guidelines and the increasing interest in plant-rich diets for cancer prevention within NHS and public health frameworks.
Key measures
Tumour cell proliferation inhibition; apoptosis induction; anti-inflammatory and antioxidant biomarkers; bladder cancer incidence or progression outcomes reported in referenced studies
Outcomes reported
The review examined the evidence for phytochemicals — including polyphenols, carotenoids, glucosinolates, and other plant-derived compounds — in the prevention and treatment of bladder cancer, likely reporting on mechanisms of action, in vitro and in vivo efficacy, and available clinical evidence.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.